KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES

被引：52

作者：

CHAPRON, DJ ^{[1
]}

KRAMER, PA ^{[1
]}

MERCIK, SA ^{[1
]}

机构：

[1] UNIV CONNECTICUT, SCH PHARM, STORRS, CT 06268 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1980年 / 27卷 / 01期

关键词：

D O I：

10.1038/clpt.1980.16

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：104 / 113

页数：10

共 28 条

[1]

BATES TR, 1977, CLIN PHARMACOL THER, V22, P917

[2]

BEYER KH, 1946, J LAB CLIN MED, V31, P65

[3]

Bratton AC, 1939, J BIOL CHEM, V128, P537

[4] EVIDENCE FOR A TRIMODAL PATTERN OF ACETYLATION OF ISONIAZID IN UREMIC SUBJECTS [J].

CHAPRON, DJ ;

BLUM, MR ;

KRAMER, PA .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (07) :1018-1019

[5] RELATIONSHIP OF SULFAMETHAZINE DISPOSITION KINETICS TO ACETYLATOR PHENOTYPE IN MAN - PRELIMINARY-STUDY [J].

CHAPRON, DJ ;

BLUM, MR .

JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (07) :338-344

[6] ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE [J].

DAS, KM ;

EASTWOOD, MA ;

MCMANUS, JPA ;

SIRCUS, W .

NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) :491-495

[7] MOLECULAR FEATURES OF SULFONAMIDE TRANSPORT IN RENAL EXCRETORY PROCESSES [J].

DESPOPOULOS, A ;

CALLAHAN, PX .

AMERICAN JOURNAL OF PHYSIOLOGY, 1962, 203 (01) :19-&

[8]

DEVADATTA S, 1960, Bull World Health Organ, V23, P587

[9]

DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251

[10] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].

EVANS, DAP ;

MANLEY, KA ;

MCKUSICK, VA .

BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491

← 1 2 3 →